Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Association between SGLT2 inhibitors and genital cancer: a meta-analysis and mendelian randomization study

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:37
  • Read more about Association between SGLT2 inhibitors and genital cancer: a meta-analysis and mendelian randomization study

Association between clonal hematopoiesis and autoimmune diseases: a bidirectional Mendelian randomization study

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:36
  • Read more about Association between clonal hematopoiesis and autoimmune diseases: a bidirectional Mendelian randomization study

Investigating the causal role of the gut microbiome in Kawasaki disease: mediating effects of immune cells

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:35
  • Read more about Investigating the causal role of the gut microbiome in Kawasaki disease: mediating effects of immune cells

Mapping the plasma metabolome to human health and disease in 274,241 adults

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:34
  • Read more about Mapping the plasma metabolome to human health and disease in 274,241 adults

Genetically modeled GLP1R and GIPR agonism reduce binge drinking and alcohol-associated phenotypes: a multi-ancestry drug-target Mendelian randomization study

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:33
  • Read more about Genetically modeled GLP1R and GIPR agonism reduce binge drinking and alcohol-associated phenotypes: a multi-ancestry drug-target Mendelian randomization study

Genetic architecture of plasma metabolome in 254,825 individuals

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:32
  • Read more about Genetic architecture of plasma metabolome in 254,825 individuals

The relationship between insomnia and multiple gastrointestinal disorders: a Mendelian randomization study

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:31
  • Read more about The relationship between insomnia and multiple gastrointestinal disorders: a Mendelian randomization study

Multiomics Mendelian randomization integrating pQTL, eQTL and mQTL data revealed BTN3A2 as a potential drug target for nephrolithiasis

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:30
  • Read more about Multiomics Mendelian randomization integrating pQTL, eQTL and mQTL data revealed BTN3A2 as a potential drug target for nephrolithiasis

Causal relationship between gut microbiota and pituitary neuroendocrine tumors: a bidirectional Mendelian randomization

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:29
  • Read more about Causal relationship between gut microbiota and pituitary neuroendocrine tumors: a bidirectional Mendelian randomization

Genetic insights into the relationship between anti-inflammatory drug target genes and oral diseases

Submitted by Anna Hakala on Thu, 11/13/2025 - 12:28
  • Read more about Genetic insights into the relationship between anti-inflammatory drug target genes and oral diseases

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 69
  • Page 70
  • Page 71
  • Page 72
  • Current page 73
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement